NEW YORK, Feb. 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This report analyzes the worldwide markets for Organ and Tissue Transplantation by Number of Procedures. The global and other markets (except the US) are analyzed only by Organ Type - Heart, Kidneys, Liver, Pancreas, and Lungs. The US market is analyzed both by Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, & Intestine) and Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts). Also, the report further analyzes the US market for Bone Graft Transplantation both by Graft Type (Autologous Graft, Allograft, and Other Materials), and by Application Type (General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 77 companies including many key and niche players such as Abiomed Inc., Arbios Systems, Inc., Arrow International, Inc., CryoLife, Inc., Exactech, Inc., Fresenius Medical Care AG & Co. KGaA, Forticell Bioscience, Inc., Gambro AB, Genzyme Corporation, Jarvik Heart, Inc., LifeCell Corporation, Medtronic, Inc., MicroMed Cardiovascular, Inc., Organogenesis, Inc., SynCardia Systems, Terumo Corporation, Thoratec Corporation, and WorldHeart Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
To order this report:
Intl: +1 805-652-2626